Skip to main content

Abstract

Objective:

Exposure to trauma reminders has been considered imperative in psychotherapy for posttraumatic stress disorder (PTSD). The authors tested interpersonal psychotherapy (IPT), which has demonstrated antidepressant efficacy and shown promise in pilot PTSD research as a non-exposure-based non-cognitive-behavioral PTSD treatment.

Method:

The authors conducted a randomized 14-week trial comparing IPT, prolonged exposure (an exposure-based exemplar), and relaxation therapy (an active control psychotherapy) in 110 unmedicated patients who had chronic PTSD and a score >50 on the Clinician-Administered PTSD Scale (CAPS). Randomization stratified for comorbid major depression. The authors hypothesized that IPT would be no more than minimally inferior (a difference <12.5 points in CAPS score) to prolonged exposure.

Results:

All therapies had large within-group effect sizes (d values, 1.32–1.88). Rates of response, defined as an improvement of >30% in CAPS score, were 63% for IPT, 47% for prolonged exposure, and 38% for relaxation therapy (not significantly different between groups). CAPS outcomes for IPT and prolonged exposure differed by 5.5 points (not significant), and the null hypothesis of more than minimal IPT inferiority was rejected (p=0.035). Patients with comorbid major depression were nine times more likely than nondepressed patients to drop out of prolonged exposure therapy. IPT and prolonged exposure improved quality of life and social functioning more than relaxation therapy.

Conclusions:

This study demonstrated noninferiority of individual IPT for PTSD compared with the gold-standard treatment. IPT had (nonsignificantly) lower attrition and higher response rates than prolonged exposure. Contrary to widespread clinical belief, PTSD treatment may not require cognitive-behavioral exposure to trauma reminders. Moreover, patients with comorbid major depression may fare better with IPT than with prolonged exposure.

Formats available

You can view the full content in the following formats:

Supplementary Material

File (appi.ajp.2014.14070908.ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 430 - 440
PubMed: 25677355

History

Received: 22 July 2014
Revision received: 21 September 2014
Revision received: 28 October 2014
Accepted: 28 October 2014
Published online: 13 February 2015
Published in print: May 01, 2015

Authors

Affiliations

John C. Markowitz, M.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Eva Petkova, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Yuval Neria, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Page E. Van Meter, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Yihong Zhao, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Elizabeth Hembree, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Karina Lovell, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Tatyana Biyanova, Ph.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.
Randall D. Marshall, M.D.
From the New York State Psychiatric Institute, New York; the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York; the Department of Child and Adolescent Psychiatry, New York University, New York; the Nathan Kline Institute for Psychiatric Research, New York; the Department of Psychiatry, University of Pennsylvania, Philadelphia; the School of Nursing, Midwifery, and Social Work, University of Manchester, Manchester, U.K.; and Retrophin, Inc., Cambridge, Mass.

Notes

Address correspondence to Dr. Markowitz ([email protected]).

Funding Information

National Institute of Mental Health10.13039/100000025: R01 MH079078
Supported by NIMH grant R01 MH079078 (Dr. Markowitz, principal investigator), and by salary support from the New York State Psychiatric Institute (Drs. Markowitz and Neria).Dr. Markowitz receives research funding from NIMH, royalties from American Psychiatric Publishing, Basic Books, and Oxford University Press, and an editorial stipend from Elsevier Press. Dr. Hembree receives royalties from Oxford University Press. Dr. Marshall is an employee of Retrophin and has been an employee of Alkermes.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share